Description:
Rompag is a thrombopoietin receptor agonist developed to boost platelet counts in patients suffering from chronic immune thrombocytopenia (ITP), aplastic anemia, and hepatitis C-related thrombocytopenia. It mimics the natural thrombopoietin hormone to stimulate the bone marrow and promote platelet production.
Rompag helps reduce the frequency of bleeding episodes and minimizes the need for platelet transfusions, offering patients a more stable and sustained recovery. With its oral administration and proven clinical outcomes, Rompag plays a pivotal role in managing chronic platelet deficiency disorders.
Share your experience with our medical product. Write a review!
29 Sep 2025
Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
29 Sep 2025
The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches
Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.
23 Jun 2025
Summer Diet Tips to Prevent Acidity and Indigestion
As temperatures rise during the summer months, many individuals experience increased instances of acidity and indigestion. The combination of heat, dietary choices, and lifestyle habits can exacerbate
18 Jun 2025
Global Health Challenges and Solutions: A Focus on Emerging Diseases
In an increasingly interconnected world, emerging diseases present significant challenges to global health systems.
